Literature DB >> 11269653

Levels of IL-8 and myeloperoxidase in the lungs of pneumonia patients.

H Abul1, A Abul, I Khan, T C Mathew, A Ayed, E Al-Athary.   

Abstract

Interleukin-8 (IL-8) is considered as the major polymorphonuclear neutrophils (PMNs) chemoattractant cytokine in lung diseases such as asthma and adult respiratory distress syndrome (ARDS). However, controversial results were obtained regarding the involvement of IL-8 in the pathogenesis of pneumonia. This study examines the role of IL-8 in the recruitment and activation of PMNs in the lung of pneumonia patients. The interesting aspect of this study is that it is a site- specific analysis of the infected and uninfected lungs of the same patient. The level of IL-8 mRNA, protein and myeloperoxidase present in the cells of the bronchioalveolar lavages (BALs) taken from the areas of known pneumonic consolidations on chest X-ray (infected lung) are compared with the BALs obtained from areas of no obvious infiltrate (non-infected lung). The results obtained from the infected and non-infected lungs of pneumonic patients were further compared with that of a control group of non-smoking patients. The level of IL-8 mRNA and protein were determined by RT-PCR and ELISA respectively. There was a significant increase in the level of IL-8 mRNA in the infected lung as compared to its level in the non-infected lung (p < 0.001). In correlation with the increase in mRNA, IL-8 protein concentrations in BAL fluids from the infected lung were 6 fold higher than those taken from the non-infected lung (p < 0.0001). This pattern was also consistent with MPO activity in the BALs (4.5 fold more MPO activity in the infected lung as compared to that of the non-infected lung), indicating that IL-8 is directly implicated in neutrophil accumulation that follows acute respiratory infection. The results of the present study, therefore, indicate the involvement of IL-8 in the pathogenesis of pneumonia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11269653      PMCID: PMC7102223          DOI: 10.1023/a:1007264411006

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  49 in total

1.  The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo.

Authors:  L H Faccioli; S Nourshargh; R Moqbel; F M Williams; R Sehmi; A B Kay; T J Williams
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

2.  Free and complexed interleukin-8 in blood and bronchial mucosa in asthma.

Authors:  J K Shute; B Vrugt; I J Lindley; S T Holgate; A Bron; R Aalbers; R Djukanović
Journal:  Am J Respir Crit Care Med       Date:  1997-06       Impact factor: 21.405

3.  Interleukin-8-induced human peripheral blood B-lymphocyte chemotaxis in vitro.

Authors:  P Schratzberger; S Dunzendorfer; N Reinisch; C M Kähler; C J Wiedermann
Journal:  Immunol Lett       Date:  1997-08       Impact factor: 3.685

4.  Interleukin-8 is a potent eosinophil chemo-attractant.

Authors:  J Shute
Journal:  Clin Exp Allergy       Date:  1994-03       Impact factor: 5.018

5.  Post-transcriptional regulation of gro alpha, beta, gamma, and IL-8 mRNAs by IL-1 beta.

Authors:  M Y Stoeckle
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

6.  Neutrophil chemotactic factors in bacterial pneumonia.

Authors:  H Hopkins; T Stull; S G Von Essen; R A Robbins; S I Rennard
Journal:  Chest       Date:  1989-05       Impact factor: 9.410

7.  Effects of ex vivo manipulation on the expression of cell adhesion molecules on neutrophils.

Authors:  P P Youssef; B X Mantzioris; P J Roberts-Thomson; M J Ahern; M D Smith
Journal:  J Immunol Methods       Date:  1995-10-26       Impact factor: 2.303

Review 8.  Pivotal role of interleukin-8 in the acute respiratory distress syndrome and cerebral reperfusion injury.

Authors:  T Matsumoto; K Yokoi; N Mukaida; A Harada; J Yamashita; Y Watanabe; K Matsushima
Journal:  J Leukoc Biol       Date:  1997-11       Impact factor: 4.962

9.  Induction of low density and up-regulation of CD11b expression of neutrophils and eosinophils by dextran sedimentation and centrifugation.

Authors:  C Berends; B Dijkhuizen; J G de Monchy; J Gerritsen; H F Kauffman
Journal:  J Immunol Methods       Date:  1994-01-03       Impact factor: 2.303

10.  Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease.

Authors:  R E Nocker; D F Schoonbrood; E A van de Graaf; C E Hack; R Lutter; H M Jansen; T A Out
Journal:  Int Arch Allergy Immunol       Date:  1996-02       Impact factor: 2.749

View more
  7 in total

1.  Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases.

Authors:  Yutong Zhao; Donghong He; Bahman Saatian; Tonya Watkins; Ernst Wm Spannhake; Nigel J Pyne; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2006-05-10       Impact factor: 5.157

2.  Measurement of cell migration in response to an evolving radial chemokine gradient triggered by a microvalve.

Authors:  Charles W Frevert; Gregory Boggy; Thomas M Keenan; Albert Folch
Journal:  Lab Chip       Date:  2006-05-12       Impact factor: 6.799

3.  Comparative aspects of murine proteinase 3.

Authors:  Manfred Relle; Thomas Thomaidis; Peter R Galle; Andreas Schwarting
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

4.  CD47 deficiency protects mice from lipopolysaccharide-induced acute lung injury and Escherichia coli pneumonia.

Authors:  Xiao Su; Mette Johansen; Mark R Looney; Eric J Brown; Michael A Matthay
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

5.  Inflammatory responses in blood samples of human immunodeficiency virus-infected patients with pulmonary infections.

Authors:  Natividad Benito; Asunción Moreno; Xavier Filella; José M Miró; Julià González; Tomás Pumarola; María Eugenia Valls; Montserrat Luna; Felipe García; Ana Rañó; Antoni Torres; José M Gatell
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

Review 6.  Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells.

Authors:  Tahereh E Zaher; Edmund J Miller; Dympna M P Morrow; Mohammad Javdan; Lin L Mantell
Journal:  Free Radic Biol Med       Date:  2007-01-17       Impact factor: 7.376

7.  Rugosic acid A, derived from Rosa rugosa Thunb., is novel inhibitory agent for NF-κB and IL-6/STAT3 axis in acute lung injury model.

Authors:  Kang-Hoon Kim; Ye-Ji Park; Hyun-Jae Jang; Seung-Jae Lee; Soyoung Lee; Bong-Sik Yun; Seung Woong Lee; Mun-Chual Rho
Journal:  Phytother Res       Date:  2020-07-21       Impact factor: 6.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.